Nyxoah Reports Fourth Quarter and Financial Year 2024 Financial and Operating Results

REGULATED INFORMATION Nyxoah Reports Fourth Quarter and Financial Year 2024 Financial and Operating Results FDA PMA Application Review Nearing Conclusion Positioned for U.S. Commercial Launch in March 2025 Mont-Saint-Guibert, Belgium – March 13, 2024, 7:00am CET / 2:00am ET – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) (“Nyxoah” or the “Company”), that develops breakthrough treatment alternatives for Obstructive Sleep Apnea (OSA) through neuromodulation, today reported financial and operating results for the fourth quarter and financial year 2024. Recent Financial and Operating Highlights Revenue for the fourth quarter of 2024 was €1.3 million, which excludes €0.6 million of deferred … Read more

Saudi Embassy in Washington Hosts Ramadan Iftar

Washington: The Saudi embassy in the United States hosted a Ramadan iftar in Washington, bringing together ambassadors from Arab and Islamic countries, representatives from the U.S. State Department, and embassy staff.

According to Saudi Press Agency…

Vice Foreign Minister Meets Spanish Ambassador

Riyadh: Vice Minister of Foreign Affairs Waleed Elkhereiji met today in Riyadh with Spanish Ambassador to Saudi Arabia Jorge Hevia Sierra, who came to bid farewell as his term as ambassador to the Kingdom concluded.

According to Saudi Press Agency, …